The Enterprise Value as of June 2026 (TTM) for Rhythm Pharmaceuticals, Inc. (RYTM) is 6.23B

According to Rhythm Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.23B. This represents a change of 3.05% compared to the average of 6.04B of the last 4 quarters.

Rhythm Pharmaceuticals, Inc. (RYTM) Historical Enterprise Value (quarterly & annually)

How has RYTM Enterprise Value performed in the past?

The mean historical Enterprise Value of Rhythm Pharmaceuticals, Inc. over the last ten years is 1.89B. The current 6.23B Enterprise Value has changed 32.82% with respect to the historical average. Over the past ten years (40 quarters), RYTM's Enterprise Value was at its highest in in the December 2025 quarter at 7.35B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Rhythm Pharmaceuticals, Inc. (RYTM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rhythm Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rhythm Pharmaceuticals, Inc. (RYTM) Average Enterprise Value

How has RYTM Enterprise Value performed in the past?

The current Enterprise Value of Rhythm Pharmaceuticals, Inc. (RYTM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Rhythm Pharmaceuticals, Inc. (RYTM) Enterprise Value vs. Peers

How is RYTM’s Enterprise Value compared to its peers?

Rhythm Pharmaceuticals, Inc.’s Enterprise Value is less than Revolution Medicines, Inc. (32.43B), greater than Akero Therapeutics, Inc. (4.32B), greater than Atrium Therapeutics, Inc. (-53572208.00), less than Protagonist Therapeutics, Inc. (6.88B), greater than Stoke Therapeutics, Inc. (1.71B), greater than uniQure N.V. (1.66B), greater than Rocket Pharmaceuticals, Inc. (275.44M), greater than Solid Biosciences Inc. (279.21M), greater than MeiraGTx Holdings plc (904.12M), less than Nuvalent, Inc. (8.91B), greater than Ventyx Biosciences, Inc. (982.56M), less than Arcellx, Inc. (6.75B), greater than Cullinan Therapeutics, Inc. (769.28M), greater than Kiniksa Pharmaceuticals, Ltd. (3.72B), greater than Pliant Therapeutics, Inc. (76.56M), greater than Syndax Pharmaceuticals, Inc. (1.83B), greater than Viridian Therapeutics, Inc. (1.35B), greater than Inozyme Pharma, Inc. (279.36M), greater than Relay Therapeutics, Inc. (2.42B), greater than Black Diamond Therapeutics, Inc. (88.09M), greater than Arvinas, Inc. (410.37M),

Build a custom stock screener for Rhythm Pharmaceuticals, Inc. (RYTM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rhythm Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rhythm Pharmaceuticals, Inc. (RYTM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rhythm Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.